We develop molecular-diagnostics reagents and assays for sample preservation, nucleic-acid extraction, and early cancer screening — moving your workflow from collection to decision with confidence.
Aequivera is a molecular-diagnostics company focused on the reagents, protocols, and assays that make liquid-biopsy and molecular testing reliable at scale. We build on a production heritage spanning specimen preservation, nucleic-acid extraction, and methylation-based cancer screening.
Our team brings together expertise in molecular biology, clinical diagnostics, and assay manufacturing. Every lot is produced under a controlled quality system, with strict release testing, so that results you generate today are reproducible next month, next quarter, and next year.
We serve hospitals, reference laboratories, and diagnostic assay developers — supplying the building blocks that turn a patient sample into an actionable clinical decision.
Talk to our team →Three areas of expertise that keep every sample result trustworthy.
Blood-collection tubes that stabilize cfDNA, cfRNA, and whole-blood RNA at ambient temperature — protecting analytes from the moment of draw through transport and long-term storage.
A validated family of purification kits — plasma cfDNA, miRNA, urine, swab, stool, and methylation conversion — engineered for high yield, low carryover, and reproducible recovery on low-abundance targets.
Methylation-based colorectal-cancer screening workflows and resistance-mutation assays designed to fit modern laboratory throughput, from sample to report.
Technology that advances diagnostics — and lives — for the better.
Develop diagnostics that laboratories trust and patients can afford.
Rigor, reproducibility, and practical reliability in everything we ship.
Manufactured under controlled quality systems and designed for laboratories that require auditable, reproducible reagent performance.
Manufacturing of preservation and extraction reagents follows the international medical-device QMS standard, with full batch traceability and release testing.
Registered for compliant circulation within the European Economic Area, confirming alignment with EU regulatory requirements for IVD reagents.
Multiple utility-model and process patents protect our preservation chemistry and extraction workflows, safeguarding the performance our customers rely on.
Request product documentation, validation data, or evaluation samples for your laboratory.
Contact us →